Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease

  • Authors:
    • Min Jiang
    • Simin Tao
    • Shaohua Zhang
    • Jing Wang
    • Fengbo Zhang
    • Fengsen Li
    • Jianbing Ding
  • View Affiliations

  • Published online on: August 20, 2019     https://doi.org/10.3892/etm.2019.7924
  • Pages: 3109-3116
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the roles of type 2 innate lymphoid cells (ILC2s) and interleukin‑33 (IL‑33) in chronic obstructive pulmonary disease (COPD). Serum and peripheral blood mononuclear cells (PBMCs) were isolated from healthy controls and COPD patients. ILC2 cells from the peripheral blood of COPD patients were stimulated with IL‑33 or neutralizing ST2 antibody+IL‑33 in vitro. The cell viability was assessed using a Cell Counting Kit‑8 assay. ELISA was used to detect serum IL‑33 and the levels of IL‑4, IL‑5, IL‑6, IL‑13 and soluble ST2 (sST2) in the culture supernatant. The percentage of ILC2 cells was measured by flow cytometry. The mRNA expression levels of GATA binding protein 3 (GATA3), RAR‑related orphan receptor (ROR)α, ST2 and prostaglandin D2 receptor 2 (CRTH2) were detected by reverse transcription‑quantitative PCR. It was revealed that IL‑33, IL‑5, IL‑6 and IL‑13 were significantly elevated in peripheral blood of patients with COPD. The proportion of ILC2s in peripheral blood of COPD patients was significantly increased, and the expression of RORA and CRTH2 was increased. The proportion of ST2+ ILC2 cells was significantly increased. After 48 h of IL‑33 stimulation in vitro, the ratio of linage‑CD45+CD127+CRTH2+ cells reached a maximum. In addition, the viability of ILC2 cells, the expression levels of RORA, GATA3, ST2 and CRTH2 mRNA and the cytokines IL‑4, IL‑6, IL‑5, IL‑13 and sST2 were significantly increased. These effects were abrogated by treatment with anti‑ST2. In conclusion, IL‑33 is upregulated in the serum of patients with COPD and the proportion of ILC2s among the PBMCs is increased. IL‑33 may promote the proliferation of ILC2 cells and secrete type 2 T‑helper cell cytokines to participate in the immune response in COPD.

Related Articles

Journal Cover

October 2019
Volume 18 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Jiang, M., Tao, S., Zhang, S., Wang, J., Zhang, F., Li, F., & Ding, J. (2019). Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine, 18, 3109-3116. https://doi.org/10.3892/etm.2019.7924
MLA
Jiang, M., Tao, S., Zhang, S., Wang, J., Zhang, F., Li, F., Ding, J."Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease". Experimental and Therapeutic Medicine 18.4 (2019): 3109-3116.
Chicago
Jiang, M., Tao, S., Zhang, S., Wang, J., Zhang, F., Li, F., Ding, J."Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease". Experimental and Therapeutic Medicine 18, no. 4 (2019): 3109-3116. https://doi.org/10.3892/etm.2019.7924